There are 2934 resources available
5130 - OCTOPUS - A Randomised, Multi-centre Phase II Umbrella Trial of Weekly Paclitaxel+/- Novel Agents in Platinum-Resistant Ovarian Cancer: vistusertib
Presenter: Susana Banerjee
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
1638 - Efficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study
Presenter: Fabrice Barlesi
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
4648 - Prognostic role of the EANO ESMO classification of leptomeningeal metastases
Presenter: Emilie Le Rhun
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
4361 - A Phase 0/2 Clinical Trial of a CDK4/6 Inhibitor in Aggressive Meningioma Patients
Presenter: Nader Sanai
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
1688 - Health-related quality of life (HRQoL) evaluation in the REGOMA trial: a randomized, phase II clinical trial analyzing regorafenib activity in relapsed glioblastoma patients
Presenter: Mario Caccese
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
Systemic treatment
Presenter: Giovanni Grignani
Session: ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment
Resources:
Slides
Webcast
Outcome of the 2019 United Nation’s high-level meeting on universal health coverage
Presenter: André Ilbawi
Session: Universal health coverage and cancer: What you and your country need to know
Resources:
Slides
Webcast
The methodology and country support for setting cancer priorities for universal health coverage
Presenter: Dario Trapani
Session: Universal health coverage and cancer: What you and your country need to know
Resources:
Slides
Webcast
Including cancer services in universal health coverage packages
Presenter: André Ilbawi
Session: Universal health coverage and cancer: What you and your country need to know
Resources:
Slides
Webcast
Yes
Presenter: Rebecca Dent
Session: Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)?
Resources:
Slides
Webcast